Diagnosis and treatment of co-occurring affective disorders and substance use disorders

Psychiatric Clinics of North America

Volumn 27, Issue 4, 2004, Pages 649-659

  Myrick, Hugh ^a,b   Cluver, Jeff ^b   Swavely, Steve ^a   Peters, Hamilton ^a  

^a Med Univ S Carolina 96 J   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; COCAINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; METHADONE; MIRTAZAPINE; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE;

ALCOHOL WITHDRAWAL; ALCOHOLISM; BEHAVIOR THERAPY; BIPOLAR DISORDER; CARDIOTOXICITY; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR DEPRESSION; MENTAL INSTABILITY; MOOD DISORDER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; REVIEW; SUBSTANCE ABUSE;

COMORBIDITY; HUMANS; MOOD DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 8844256068     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2004.06.003     Document Type: Review

References (46)

1. D.A. Regier, M.E. Farmer, D.S. Rae, B.Z. Locke, S.J. Keith, and L.L. Judd Comorbidity of mental disorders with alcohol and other drug abuse JAMA 264 1990 2511 2518
2. R.C. Kessler, C.B. Nelson, K.A. McGonagle, M.J. Edlund, R.G. Frank, and P.J. Leaf The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization Am J Orthopsychiatry 66 1996 17 31
3. M.J. Bohn, T.F. Babor, and H.R. Kranzler The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings J Stud Alcohol 56 1995 423 432
4. L.M. Teitelbaum, and K.B. Carey Temporal stability of alcohol screening measures in a psychiatric setting Psychol Addict Behav 14 2000 401 404
5. K.M. Cocco, and K.B. Carey Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients Psychol Assess 10 1998 408 414
6. S.A. Maisto, M.P. Carey, K.B. Carey, C.M. Gordon, and J.R. Gleason Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness Psychol Assess 12 2000 186 192
7. K. Skipsey, J.A. Burleson, and H.R. Kranzler Utility of the AUDIT for identification of hazardous or harmful drinking in drug-dependent patients Drug Alcohol Depend 45 1997 157 163
8. I.H. Franken, and V.M. Hendriks Screening and diagnosis of anxiety and mood disorders in substance abuse patients Am J Addict 10 2001 30 39
9. H.R. Kranzler, R.M. Kadden, T.F. Babor, H. Tennen, and B.J. Rounsaville Validity of the SCID in substance abuse patients Addiction 91 1996 859 868
10. D.S. Hasin, K.D. Trautman, G.M. Miele, S. Samet, M. Smith, and J. Endicott Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers Am J Psychiatry 153 1996 1195 1201
11. D.H. Barlow, and C.L. Lehman Advances in the psychosocial treatment of anxiety disorders: implications for national health care Arch Gen Psychiatry 53 1996 727 735
12. R.F. Anton, D.H. Moak, L.R. Waid, P.K. Latham, R.J. Malcolm, and J.K. Dias Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial Am J Psychiatry 156 1999 1758 1764
13. W.E. Brown, and M. Schuckit Changes in depression among abstinent alcoholics J Stud Alcohol 49 1988 412 417
14. K.T. Brady, and S.C. Sonne The role of stress in alcohol use, alcoholism treatment, and relapse Alcohol Res Health 23 1999 263 271
15. R.K. Brooner, V.L. King, M. Kidorf, C.W. Schmidt Jr., and G.E. Bigelow Psychiatric and substance comorbidity among treatment-seeking opioid abusers Arch Gen Psychiatry 54 1997 71 80
16. B.J. Mason, J.H. Kocsis, E.C. Ritvo, and R.B. Cutler A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression JAMA 275 1996 761 767
17. P.J. McGrath, E.V. Nunes, J.W. Stewart, D. Goldman, V. Agosti, and K. Ocepek-Welikson Imipramine treatment of alcoholics with primary depression: a placebo-controlled clinical trial Arch Gen Psychiatry 53 1996 232 240
18. D.A. Gorelick Serotonin uptake blockers and the treatment of alcoholism Recent Dev Alcohol 7 1989 267 281
19. J.R. Cornelius, I.M. Salloum, J.G. Ehler, P.J. Jarrett, M.D. Cornelius, and J.M. Perel Fluoxetine in depressed alcoholics: a double-blind, placebo-controlled trial Arch Gen Psychiatry 54 1997 700 705
20. H.R. Kranzler, J.A. Burleson, P. Korner, F.K. Del Boca, M.J. Bohn, and J. Brown Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics Am J Psychiatry 152 3 1995 391 397
21. D. Kabel, and F. Petty A double-blind study of fluoxetine in severe alcohol dependence: adjunctive therapy during and after inpatient treatment Alcohol Clin Exp Res 20 1996 780 784
22. T.F. Babor, M. Hofmann, F.K. DelBoca, V. Hesselbrock, R.E. Meyer, and Z.S. Dolinsky Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity Arch Gen Psychiatry 49 8 1992 599 608
23. H.R. Kranzler, J.A. Burleson, J. Brown, and T.F. Babor Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics Alcohol Clin Exp Res 20 9 1996 1534 1541
24. H.M. Pettinati, J.R. Volpicelli, H.R. Kranzler, G. Luck, M.R. Rukstalis, and A. Cnaan Sertraline treatment for alcohol dependence. Interactive effects of medication and alcoholic subtype Alcohol Clin Exp Res 24 7 2000 1041 1049
25. E.V. Nunes, F.M. Quitkin, S.J. Donoval, D. Deliyannides, K. Ocepek-Welikson, and T. Koenig Imipramine treatment of opiate-dependent patients with depressive disorders Arch Gen Psychiatry 55 1998 153 160
26. S. Rao, D. Ziedonis, and T. Kosten The pharmacotherapy of cocaine dependence Psychiatr Ann 25 1995 363 368
27. J.M. Schmitz, P. Averill, A.L. Stotts, F.G. Moeller, H.M. Rhoades, and J. Grabowski Fluoxetine treatment of cocaine-dependent patients with major depressive disorder Drug Alcohol Depend 63 2001 207 214
28. I. Petrakis, K.M. Carroll, C. Nich, L. Gordon, T. Kosten, and B. Rounsaville Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts Drug Alcohol Depend 50 1998 221 226
29. D.M. McDowell, F.R. Levin, A.M. Seracini, and E.V. Nunes Venlafaxine treatment of cocaine abusers with depressive disorders Am J Drug Alcohol Abuse 26 1 2000 25 31
30. R.A. Brown, D.M. Evans, I.W. Miller, E.S. Burgess, and T.I. Mueller Cognitive-behavioral treatment for depression in alcoholism J Consult Clin Psychol 65 5 1997 715 726
31. J.F. Goldberg, J.L. Garno, A.C. Leon, J.H. Kocsis, and L. Portera A history of substance abuse complicates remission from acute mania in bipolar disorder J Clin Psychiatry 60 11 1999 733 740
32. C.L. Bowden Predictors of response to divalproex and lithium J Clin Psychiatry 56 1995 25
33. B. Geller, T. Cooper, K. Sun, B. Zimerman, J. Frazier, and M. Williams Double-blind and placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependency J Am Acad Child Adolesc Psychiatry 37 2 1998 171 178
34. K.T. Brady, S.C. Sonne, and R. Anton Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study J Clin Psychiatry 56 1995 118 121
35. R.D. Weiss, S.F. Greenfield, L.M. Najavits, J.A. Soto, D. Wyner, and M. Tohen Medication compliance among patients with bipolar disorder and substance use disorder J Clin Psychiatry 59 1998 172 174
36. K.T. Brady, H. Myrick, S. Henderson, and S.F. Coffey The use of divalproex in alcohol relapse prevention: a pilot study Drug Alcohol Depend 67 2002 323 330
37. I. Salloum, J.R. Cornelius, D.C. Daley, and L. Kirisci Efficacy of valproate maintenance in bipolar alcoholics: preliminary findings Proceedings of the American Academy of Addiction Psychiatry 2002 63
38. H. Myrick, R. Malcolm, and R. Anton The use of antiepileptics in the treatment of addictive disorders Primary Psychiatry 10 10 2003 59 63
39. R. Malcolm, J.C. Ballenger, E.T. Sturgis, and R. Anton Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal Am J Psychiatry 146 1989 617 621
40. C.H. Stuppaeck, R. Pycha, C. Miller, A.B. Whitworth, H. Oberbauer, and W.W. Fleischhacker Carbamazepine versus oxazepam in the treatment of alconol withdrawal: a double blind study Alcohol Alcohol 27 1991 153 158
41. H. Myrick, K.T. Brady, and R. Malcolm Divalproex in the treatment of alcohol withdrawal Am J Drug Alcohol Abuse 26 2000 155 160
42. J.P. Reoux, A.J. Saxon, C.A. Malte, J.S. Baer, and K.L. Sloan Divalproex in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial Alcohol Clin Exp Res 25 2001 1324 1329
43. L.P. Longo, C. Campbell, and S. Hubatch Divalproex sodium for alcohol withdrawal and relapse prevention J Addict Dis 21 2002 55 64
44. T.I. Mueller, R.L. Stout, S. Ruden, R.A. Brown, A. Gordon, and D.A. Solomon A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence Alcohol Clin Exp Res 1 1997 86 92
45. B.A. Johnson, N. Ait-Daoud, C.L. Bowden, C.C. DiClemente, J.D. Roache, and K. Lawson Oral topiramate for the treatment of alcohol dependence: a randomised controlled trial Lancet 361 2003 1677 1685
46. R.D. Weiss, M.L. Griffin, S.F. Greenfield, L.M. Najavits, D. Wyner, and J.A. Soto Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study J Clin Psychiatry 61 2000 361 367